Laporan Laba Rugi (TTM)
Laporan Laba Rugi Shanghai Bio-heart Biological Technology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2025 03-31 |
2025 06-30 |
|
|---|---|---|
| Revenue | 10 | 21 |
| Change (%) | 100.00 | |
| % of Revenue | 100.00 | 100.00 |
| Cost Of Sales | 6 | 11 |
| Change (%) | 100.00 | |
| % of Revenue | 53.53 | 53.53 |
| Gross Operating Profit | 5 | 10 |
| Change (%) | 100.00 | |
| % of Revenue | 46.47 | 46.47 |
| SG&A | 22 | 23 |
| Change (%) | 8.68 | |
| % of Revenue | 207.23 | 112.61 |
| R&D | 40 | 40 |
| Change (%) | -2.10 | |
| % of Revenue | 387.78 | 189.81 |
| OpEx | 68 | 74 |
| Change (%) | 9.77 | |
| % of Revenue | 648.54 | 355.95 |
| Operating Income | -57 | -53 |
| Change (%) | -6.68 | |
| % of Revenue | -548.54 | -255.95 |
| Interest Expense | -2 | -4 |
| Change (%) | 96.41 | |
| % of Revenue | -17.09 | -16.79 |
| Net Income | -89 | -89 |
| Change (%) | 0.78 | |
| % of Revenue | -849.73 | -428.18 |
Source: Capital IQ
